Tag: #M&A

Defying its long-standing reputation as a potential takeover target, Neurocrine Biosciences has taken a decisive step by acquiring Soleno Therapeutics... Read more

Samsung Biologics, a leading contract development and manufacturing organization (CDMO), has completed the acquisition of GSK’s manufacturing site in Rockville,... Read more

Eli Lilly has agreed to acquire Centessa Pharmaceuticals for up to $47 per share, valuing the transaction at approximately $7.8... Read more

In a strategic move to accelerate near-term revenue growth, Biogen has announced a definitive agreement to acquire Apellis Pharmaceuticals for... Read more

On March 27, 2026, Novartis announced an agreement to acquire Excellergy, Inc., a private biotech firm specializing in next-generation anti-IgE... Read more

On March 25, 2026, MSD (known as Merck & Co. in the US) announced a definitive agreement to buy cancer... Read more

On March 20, 2026, Swiss pharma giant Novartis announced the acquisition of Pikavation Therapeutics (a subsidiary of Synnovation Therapeutics) to... Read more

In a move to solidify its leadership in the attention-deficit/hyperactivity disorder (ADHD) market, Massachusetts-based Collegium Pharmaceutical has struck a deal... Read more

The strategic transaction is projected to conclude in the second quarter of 2026, signaling a significant expansion for the French... Read more